Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 197

MS-Japan recruits Hayate for fund

The $19.3m MS Hayate Fund will be jointly run by Matching Service Japan and Hayate Investment for a period of up to nine years.

Feb 5, 2021

MPL levels up with $95m series D

SIG, Gojek and Telstra helped mobile gaming platform developer Mobile Premier League roughly double its valuation to $975m.

Feb 4, 2021

Daily deal net: February 4, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Feb 4, 2021

Cialfo clears series A with $15m

Susquehanna International Group co-led a round for the education applicant software developer that has been boosted by a $12m extension.

Feb 4, 2021

YanRong Tech yanks in series A-plus funding

UCap Oceanwide Fund was among the participants as the database management software developer pulled in $18.6m in early-stage financing.

Feb 4, 2021

Huakang Pharmaceutical hikes to $232m IPO

HY Energy and Yake Food-backed starch sugar additive manufacturer Zhejiang Huakang Pharmaceutical is set to go public in Shanghai.

Feb 3, 2021

Resproly inhales $31m in series B round

Gree and Shanghai Kindly-backed, respiratory-focused medical device and drug developer Resproly has closed a round led by CAS Investment Management.

Feb 3, 2021

Resproly inhales $31m series B

CAS Investment Management, a subsidiary of Chinese Academy of Sciences, has backed medical devices developer Resproly’s series B round.

Feb 3, 2021

NeoX Biotech nets $30m

Bertelsmann Asia Investments contributed to a series A round that will fund preclinical development of NeoX's immuno-oncology drug pipeline.

Feb 3, 2021

Kringle Pharma reaches public markets

Chishima Real Estate, M3, Miraca, Nippon Life, POC Clinical Research, Reprocell, Toho Holdings and Zenoaq have all scored exits after the cell therapy provider went public.

Feb 3, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here